|
시장보고서
상품코드
2038952
호르몬 제제 시장 : 제품 유형별, 투여 경로별, 용도별, 유통 채널별, 지역별Hormonal Drugs Market, By Product Type, By Route of Administration, By Application, By Distribution Channel, By Geography |
||||||
호르몬 제제 시장은 2026년에 750억 달러로 추정되고 있으며, 2033년까지 1,020억 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 4.49%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 750억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 4.49% | 2033년 시장 규모 예측 : | 1,020억 달러 |
세계의 호르몬 제제 시장은 전체 제약 산업에서 중요한 부문입니다. 이 약물은 당뇨병, 갑상선 질환, 생식기 건강 문제, 성장호르몬 결핍증, 호르몬 관련 암 등 다양한 질병을 치료하는 데 사용되고 있습니다. 주요 부문에는 인슐린, 갑상선 호르몬,성 호르몬, 코르티코 스테로이드, 성장호르몬, 호르몬 대체요법 등이 있습니다. 생활습관병의 증가와 고령화 사회로 인해 호르몬 제제에 대한 수요가 증가하고 있습니다.
시장 성장은 헬스케어에 대한 인식의 증가, 약물전달 시스템 및 진단 기술의 발전으로 인해 더욱 촉진되고 있습니다. 호르몬 대체요법의 보급, 바이오시밀러의 개발, 그리고 개인맞춤형 의료는 치료의 수행 방식에 혁명을 불러일으키고 있습니다. 또한 모니터링 및 투약 관리에 디지털 기술을 도입하는 것도 시장에 긍정적인 영향을 미치고 있습니다. 세계 호르몬제제 시장에 크게 기여하고 있는 주요 응용 분야로는 당뇨병 관리, 갱년기 치료, 불임 치료, 소아 성장 장애 등이 있습니다.
시장 역학
호르몬 제제 시장은 전 세계 수억 명에게 영향을 미치고 인슐린 주사를 통한 호르몬 관리가 필요한 당뇨병과 같은 내분비 질환의 발병률 증가에 의해 주도되고 있습니다. 평균 수명의 연장은 에스트로겐과 테스토스테론 결핍과 같은 호르몬 장애의 증가에도 기여하고 있으며, 이는 호르몬 대체요법으로 관리되고 있습니다. 또한 생식 및 불임 문제, 피임에 대한 인식의 증가, 특히 의료 인프라가 구축되고 있는 개발도상국에서 피임에 대한 인식이 높아지는 것도 이 시장의 성장에 기여하고 있습니다. 동시에 약물전달 시스템의 기술 혁신도 진행되고 있습니다.
큰 성장 요인이 존재하는 반면, 시장은 복잡한 규제 요건과 같은 도전에 직면하고 있으며, 이는 개발 비용의 증가로 이어지고 있습니다. 심혈관계 및 암과 관련된 부작용과 같은 장기적인 안전성에 대한 우려도 호르몬 제제의 사용에 영향을 미칠 수 있습니다. 시장을 선도하는 의약품의 특허만료로 인해 제네릭 의약품이 증가하고 있으며, 이는 개발된 오리지널 의약품의 가격 책정에도 영향을 미치고 있습니다.
그러나 호르몬제 시장에는 비용 효율적이면서도 높은 효능을 겸비한 바이오시밀러라는 새로운 기회가 생겨나고 있습니다. 호르몬 민감성 종양 등 암 치료에서 호르몬 요법의 사용 확대는 시장에 새로운 수입원을 창출하고 있습니다. 또한 유전자 프로파일링과 같은 맞춤형 의료를 도입할 수 있는 기회도 시장에 새로운 수입원을 가져다주고 있습니다.
본 조사의 주요 특징
- 이 보고서는 다양한 부문의 잠재적 매출 창출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하고 있는 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계의 호르몬제 시장의 주요 기업 개요을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 세계의 호르몬 제제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 호르몬 제제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 호르몬 제제 시장 : 제품 유형별, 2021-2033년
제5장 세계의 호르몬 제제 시장 : 투여 경로별, 2021-2033년
제6장 세계의 호르몬 제제 시장 : 용도별, 2021-2033년
제7장 세계의 호르몬제 시장 : 유통 채널별, 2021-2033년
제8장 세계의 호르몬제 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 애널리스트의 추천
제11장 참고 문헌 및 조사 방법
KSA 26.06.02Hormonal Drugs Market is estimated to be valued at USD 75 Bn in 2026 and is expected to reach USD 102 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.49% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 75 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.49% | 2033 Value Projection: | USD 102 Bn |
The global hormonal drugs market is an important segment of the overall pharmaceutical industry. These drugs are used to treat a wide range of conditions, including diabetes, thyroid disorders, reproductive health issues, growth hormone deficiencies, and hormone-related cancers. Key segments include insulin, thyroid hormones, sex hormones, corticosteroids, growth hormones, and hormone replacement therapies. The increasing incidence of lifestyle-related conditions and the growing geriatric population are increasing the demand for hormonal drugs.
The market growth is further fueled by increasing healthcare awareness, development in drug delivery systems, and diagnostics. Acceptance of hormone replacement therapies, development of biosimilars, and personalized medicine is revolutionizing the way in which treatments are being carried out. Moreover, incorporation of digital technologies in monitoring and dose management is also contributing positively. Some of the major application segments that have been contributing significantly to the global hormonal drugs market include diabetes management, menopause therapy, fertility treatments, and pediatric growth disorders.
Market Dynamics
The hormonal drugs market is driven by the rising incidence rate of endocrine disorders like diabetes mellitus, which affects hundreds of millions worldwide and requires hormonal management in the form of insulin injections. The increase in life expectancy is also contributing to hormonal disorders like estrogen and testosterone deficiency, which is being managed through hormone replacement therapies. In addition, awareness about reproductive and fertility issues, as well as contraceptive practices, especially in developing nations with improving healthcare infrastructures, is also contributing to the growth of this market. At the same time, technological innovations in drug delivery systems are improving.
Despite the presence of significant growth drivers, the market faces challenges such as regulatory requirements, which are becoming complex, leading to an increase in the cost of development. Long-term safety concerns, such as those of cardiovascular and cancer-related side effects, may also affect the use of hormonal drugs. Patent expiration of leading drugs in the market has led to an increase in generics, which in turn is affecting the pricing of the original drugs developed.
However, the market for hormonal drugs presents an opportunity, which is in the form of biosimilars, which are both cost-effective and highly effective. The expansion of the use of hormonal therapies in cancer, such as hormone-sensitive tumors, is creating new revenue streams for the market. Additionally, the opportunity to include personalized medicine, such as genetic profiling, is creating new revenue streams for the market.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global hormonal drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer Inc, Merck, Novartis AG, Hoffmann La Roche Ltd, Sanofi, Novo Nordisk A/S, Eli Lilly and Company, AbbVie Inc, Bayer AG, and Teva Pharmaceutical Industries Ltd
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global hormonal drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hormonal drugs market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Insulin and Analogues
- Testosterone Therapies
- Thyroid Hormone Therapies
- Estrogen and Progesterone Therapies
- Human Growth Hormone (HGH)
- Corticosteroids
- Gonadotropins (FSH, LH, hCG)
- Others
- Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Oral
- Parenteral/ Injectable
- Transdermal
- Nasal
- Others
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Endocrine Disorders
- Reproductive Health
- Oncology
- Growth Disorders
- Others
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc
- Merck
- Novartis AG
- Hoffmann La Roche Ltd
- Sanofi
- Novo Nordisk A/S
- Eli Lilly and Company
- AbbVie Inc
- Bayer AG
- Teva Pharmaceutical Industries Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Hormonal Drugs Market, By Product Type
- Global Hormonal Drugs Market, By Route of Administration
- Global Hormonal Drugs Market, By Application
- Global Hormonal Drugs Market, By Distribution Channel
- Global Hormonal Drugs Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Hormonal Drugs Market, By Product Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Insulin and Analogues
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Testosterone Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Thyroid Hormone Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Estrogen and Progesterone Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Human Growth Hormone (HGH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Gonadotropins (FSH, LH, hCG)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Hormonal Drugs Market, By Route of Administration, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Parenteral/ Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Transdermal
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Nasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Hormonal Drugs Market, By Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Endocrine Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Reproductive Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Growth Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Hormonal Drugs Market, By Distribution Channel, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Hormonal Drugs Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
